EE443 Costs Avoided by the Inclusion of Finerenone Based on Hospitalization and Death Due to Cardiovascular Events and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia
Abstract
Authors
Claudia A. López-Cabra Ángela Daniela Rodríguez wilson Mayorga Mogollon Diana Smith Lopez Silvia Juliana Rey Laura Idrobo DIANA C. ACOSTA Diana Gutierrez Ruben D. Marrugo